This article discusses literally a couple dozen vaccines and drugs that are in development for Ebola. How is their testing being fast-tracked ?
One Comment
Comments are closed.
Today I told another patient that in fact, there was no need to be so worried about the pandemic. Used early, hydroxychloroquine worked very effectively as a treatment. And again the first thing I heard was, “Isn’t that the drug Trump talked about?” Why does what Trump said seem more germane to people than the…
https://www.washingtonpost.com/politics/2022/01/11/most-people-are-going-get-covid-momentous-warning-senate-hearing/ “I think it’s hard to process what’s actually happening right now,” said Janet Woodcock, acting commissioner of the Food and Drug Administration, “which is most people are going to get covid.” Woodcock pitched this as being a necessary acknowledgment when it comes to charting the path forward — recognizing that the focus now needs…
Dr. Paul Offit, head of pediatric infectious diseases at Children’s Hospital, Philadelphia PA, and originator of a licensed Rotavirus vaccine recommended for all children, is an inveterate vaccine booster. In his Oct 11 NYTimes Op-ed, he makes four claims about the new swine flu vaccine. I’ll briefly comment on each. 1. The vaccine is safe because…
Drugs and devices licensed in the US often rely on data generated overseas for FDA approval. It should come as no surprise that FDA oversight of foreign clinical trials may be weak or nonexistent, and that drug/device approvals today seem more and more likely to be based on data whose reliability is far from assured…especially…
Two members of an FDA advisory committee quit after approval of controversial Alzheimer’s drug. (excerpt): Heated debate continues over the clearance of Aduhelm despite opposition from agency’s outside experts Two members of a Food and Drug Administration advisory panel resigned this week after the agency’s contentious decision to approve an Alzheimer’s drug over the objections of its outside…
Now here is a very surprising editorial from the Aug. 7 Australian. It was penned by Lawrence O. Gostin, now a visiting professor at the University of Sydney. Gostin authored the Model State Emergency Health Powers Act, on contract to CDC. Versions (or parts) of the Act have been passed so far in 38 states….
Comments are closed.
So far the Morpholino oligos have not been fast tracked as far as I know; there is no funding for their further development. More citations describing their development and clinical testing are here: http://www.gene-tools.com/content/citations-morpholino-work-ebola-or-marburg-filovirus